Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular function.
Saved in:
| Title: | Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular function. |
|---|---|
| Authors: | Barés G; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain., Beà A; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain., Sancho-Balsells A; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Valero JG; Department of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Barcelona, Spain., Aluja D; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain., Inserte J; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain., García-Carpi S; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain., Miró-Casas E; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain., Borràs-Pernas S; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Hernández S; IRBLleida, Lleida, Spain.; Experimental Neuromuscular pathology Group, Departament de Medicina Experimental, Universitat de Lleida and IRBLleida, Lleida, Spain., Martínez-Val A; Novo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Olsen JV; Novo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Tebar F; Departament de Biomedicina, Unitat de Biologia Cellular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Spain.; Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Cañas X; Institut de Recerca Sant Joan de Deu Barcelona, Madrid, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain., Comella JX; Institut de Recerca Sant Joan de Deu Barcelona, Madrid, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain., Pérez-Galán P; Department of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Barcelona, Spain., Ruiz-Meana M; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain., Giralt A; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Llovera M; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain., Sanchis D; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain. |
| Source: | The FEBS journal [FEBS J] 2025 Oct; Vol. 292 (19), pp. 5105-5129. Date of Electronic Publication: 2025 Mar 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40123200 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular function. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Barés+G%22">Barés G</searchLink>; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Beà+A%22">Beà A</searchLink>; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Sancho-Balsells+A%22">Sancho-Balsells A</searchLink>; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Valero+JG%22">Valero JG</searchLink>; Department of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Aluja+D%22">Aluja D</searchLink>; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Inserte+J%22">Inserte J</searchLink>; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Carpi+S%22">García-Carpi S</searchLink>; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Miró-Casas+E%22">Miró-Casas E</searchLink>; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Borràs-Pernas+S%22">Borràs-Pernas S</searchLink>; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández+S%22">Hernández S</searchLink>; IRBLleida, Lleida, Spain.; Experimental Neuromuscular pathology Group, Departament de Medicina Experimental, Universitat de Lleida and IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Val+A%22">Martínez-Val A</searchLink>; Novo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Olsen+JV%22">Olsen JV</searchLink>; Novo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Tebar+F%22">Tebar F</searchLink>; Departament de Biomedicina, Unitat de Biologia Cellular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Spain.; Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cañas+X%22">Cañas X</searchLink>; Institut de Recerca Sant Joan de Deu Barcelona, Madrid, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Comella+JX%22">Comella JX</searchLink>; Institut de Recerca Sant Joan de Deu Barcelona, Madrid, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Galán+P%22">Pérez-Galán P</searchLink>; Department of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ruiz-Meana+M%22">Ruiz-Meana M</searchLink>; Cardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.; CIBER de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Giralt+A%22">Giralt A</searchLink>; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Production and Validation Center of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Llovera+M%22">Llovera M</searchLink>; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchis+D%22">Sanchis D</searchLink>; Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.; IRBLleida, Lleida, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101229646%22">The FEBS journal</searchLink> [FEBS J] 2025 Oct; Vol. 292 (19), pp. 5105-5129. <i>Date of Electronic Publication: </i>2025 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Blackwell+Pub%2E+on+behalf+of+the+Federation+of+European+Biochemical+Societies%22">Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101229646 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1742-4658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221742464X%22">1742464X </searchLink><i>NLM ISO Abbreviation: </i>FEBS J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40123200 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/febs.70077 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5105 Titles: – TitleFull: Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular function. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Barés G – PersonEntity: Name: NameFull: Beà A – PersonEntity: Name: NameFull: Sancho-Balsells A – PersonEntity: Name: NameFull: Valero JG – PersonEntity: Name: NameFull: Aluja D – PersonEntity: Name: NameFull: Inserte J – PersonEntity: Name: NameFull: García-Carpi S – PersonEntity: Name: NameFull: Miró-Casas E – PersonEntity: Name: NameFull: Borràs-Pernas S – PersonEntity: Name: NameFull: Hernández S – PersonEntity: Name: NameFull: Martínez-Val A – PersonEntity: Name: NameFull: Olsen JV – PersonEntity: Name: NameFull: Tebar F – PersonEntity: Name: NameFull: Cañas X – PersonEntity: Name: NameFull: Comella JX – PersonEntity: Name: NameFull: Pérez-Galán P – PersonEntity: Name: NameFull: Ruiz-Meana M – PersonEntity: Name: NameFull: Giralt A – PersonEntity: Name: NameFull: Llovera M – PersonEntity: Name: NameFull: Sanchis D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1742-4658 Numbering: – Type: volume Value: 292 – Type: issue Value: 19 Titles: – TitleFull: The FEBS journal Type: main |
| ResultId | 1 |